Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Operating Expenses (2016 - 2025)

Historic Operating Expenses for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $352.3 million.

  • National Healthcare's Operating Expenses rose 1098.71% to $352.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1923.97%. This contributed to the annual value of $1.2 billion for FY2024, which is 1265.31% up from last year.
  • Latest data reveals that National Healthcare reported Operating Expenses of $352.3 million as of Q3 2025, which was up 1098.71% from $340.8 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Operating Expenses registered a high of $352.3 million during Q3 2025, and its lowest value of $235.8 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $285.2 million, with a median of $274.3 million in 2021.
  • Per our database at Business Quant, National Healthcare's Operating Expenses plummeted by 684.86% in 2022 and then surged by 2271.42% in 2024.
  • Quarter analysis of 5 years shows National Healthcare's Operating Expenses stood at $274.3 million in 2021, then fell by 6.85% to $255.5 million in 2022, then grew by 9.9% to $280.8 million in 2023, then rose by 22.71% to $344.6 million in 2024, then grew by 2.24% to $352.3 million in 2025.
  • Its last three reported values are $352.3 million in Q3 2025, $340.8 million for Q2 2025, and $342.9 million during Q1 2025.